Inspire Medical Systems, Inc. (INSP)
US — Healthcare Sector
Automate Your Wheel Strategy on INSP
With Tiblio's Option Bot, you can configure your own wheel strategy including INSP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INSP
- Rev/Share 30.0903
- Book/Share 22.7209
- PB 3.1733
- Debt/Equity 0.0489
- CurrentRatio 5.2912
- ROIC 0.045
- MktCap 2132308039.0
- FreeCF/Share 3.3689
- PFCF 21.5781
- PE 47.4654
- Debt/Assets 0.0403
- DivYield 0
- ROE 0.0668
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | INSP | RBC Capital Mkts | Outperform | Sector Perform | -- | $90 | Jan. 27, 2026 |
| Downgrade | INSP | Oppenheimer | Outperform | Perform | -- | -- | Jan. 22, 2026 |
| Downgrade | INSP | Truist | Buy | Hold | -- | $96 | Jan. 22, 2026 |
| Upgrade | INSP | Oppenheimer | Perform | Outperform | -- | $175 | Dec. 8, 2025 |
| Downgrade | INSP | Morgan Stanley | Overweight | Equal Weight | -- | $130 | Dec. 2, 2025 |
| Upgrade | INSP | Truist | Hold | Buy | -- | $165 | Nov. 26, 2025 |
| Upgrade | INSP | Wolfe Research | Peer Perform | Outperform | -- | $180 | Nov. 25, 2025 |
| Upgrade | INSP | Stifel | Hold | Buy | -- | -- | Nov. 24, 2025 |
| Upgrade | INSP | Wells Fargo | Equal Weight | Overweight | -- | $90 | Nov. 4, 2025 |
| Downgrade | INSP | Jefferies | Buy | Hold | -- | $85 | Oct. 24, 2025 |
News
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
INSP
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
INSP
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Read More
About Inspire Medical Systems, Inc. (INSP)
- IPO Date 2018-05-03
- Website https://www.inspiresleep.com
- Industry Medical - Devices
- CEO Timothy Herbert
- Employees 1246
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.